Company intelligence / Profile preview

Advanced Magnetic Research Institute International

Ownership: Private
Development stage: Other

Overview

The company developed and promoted the MME device for a wide range of serious neurological and orthopedic conditions. Clinical results are not published in peer-reviewed literature. The FDA issued warnings regarding unapproved human trials and lack of IRB oversight. There have been reports of adverse events including deaths and cancer cases following treatment, though causality was disputed by the company[7]. No robust clinical efficacy data are available.

Therapeutic areas: CardiovascularRheumatologyNeurology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

None reported with major pharmaceutical or biotech companies.

Beyond the preview

Go deeper on Advanced Magnetic Research Institute International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Magnetic Research Institute International.

Explore the full profile